The following pages and information are intended solely for specialists, i.e. persons authorised to prescribe or dispense medicinal products (definition of a specialist in accordance with Section 2a of Act No. 40/1995 Coll., on advertising regulation, as amended). If this does not apply to you, then you are strongly advised to be aware of the risks associated with incorrectly interpreting the claims stated in the information on these pages.
By clicking the YES button (continue), you expressly declare and confirm that you are a specialist, i.e. a person authorised to dispense or prescribe medicinal products. If you are not a person authorised to prescribe or dispense medicinal products, you may leave this page by clicking the NO button.
By clicking on the YES button (continue), you expressly declare and confirm that you are aware of the definition of a specialist. If this does not apply to you or you are not a person authorised to prescribe or dispense medicinal products, you may leave this page by clicking the NO button.
If you are not a specialist, then you are aware of the risks you expose yourself to as a consequence of incorrectly interpreting information that is intended for specialists and you completely accept these risks.
- By title ascending
- By title descending
- By date of publication ascending
- By date of publication descending
Gynefix® is a new non-hormonal IUD without hard plastic body. Due to its design and method of insertion it is suitable for most women including nulliparous women.
Clormetin is a hormonal contraceptive containing ethinylestradiol and progestin chlormadinone acetate available in our market since November 2011.
Ayreen is an oral contraceptive containing ethinylestradiol and the progestin dienogest.
Yosefinne is an oral contraceptive containing ethinylestradiol and the progestin drospirenone in the dosing regimen of 24 active tablets +4 placebo tablets.
Evellien is an oral, progestogen-only contraceptive containing the progestin desogestrel.
Birgi is an oral contraceptive containing progestin gestodene and ethinylestradiol in the dosing regimen of 24 active tablets + 4 placebo tablets.
Tibolon Aristo 2,5 mg se používá k léčbě příznaků nedostatku estrogenů u žen, které jsou alespoň jeden rok po menopauze.
Yollie 3 mg/0,02 mg potahované tablety se používá jako perorální kontracepce.
Terapie středně těžkých až těžkých příznaků benigní hyperplazie prostaty (BHP). Jedna měkká tobolka obsahuje dutasteridum 0,5 mg.